dr. kelley on newly approved agents in hcc
Published 6 years ago • 268 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
0:51
dr. kelley on the development of biomarkers for hcc
-
1:20
dr. kelley discusses rising incidences of hcc
-
1:22
dr. el-khoueiry on choosing between lenvatinib and sorafenib in hcc
-
1:45:37
embarking on a new treatment era in hcc: a personal take on integrating recent evidence into care
-
14:37
how to integrate new agents in hcc: the role of checkpoint inhibitors
-
12:34
everything about liver cancer - learn about its diagnosis and treatment
-
20:45
ct scan liver normal vs hepatocellular carcinoma (hcc) images | liver cancer imaging diagnoses
-
45:53
hepatocellular carcinoma
-
1:16
dr. el-khoueiry on the frontline treatment landscape in hcc
-
2:03
dr. kaseb on research with targeted therapy in hcc
-
1:09
dr. greten on promising immunotherapy agents in hcc
-
59:57
exploring new treatment options in hcc
-
7:10
evidence with checkpoint inhibition in hcc
-
1:15
dr. huey on the importance of patient selection in hcc
-
14:19
new targets and new agents in hcc
-
1:36
dr. singal discusses recent clinical trials in hcc
-
1:05:05
hcc: optimizing outcomes with new and emerging treatment approaches
-
1:38
celestial trial: assessing outcomes by afp levels in hcc
-
1:04
dr. singal on the potential for immunotherapy in hcc
-
2:24
emerging i-o combination trials in unresectable hcc
-
1:35
dr. el-khoueiry on evolving role of immunotherapy in hcc
-
0:54
dr. singal on the fda approval of cabozantinib in hcc